Læknablaðið : fylgirit - 01.05.1978, Qupperneq 47

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 47
SAUCYIATE SCRUM CONCENTRATION (MEAN2&Q) pmol/l mg/100 ml TME FlRST OAY OE ADMINISTRATION THE 10 1h OAV OF AOMINISTRATION TIME (houf*) TlME(hours) Fig. 2 Salicylate serum levels on the first and 1 Oth day of the test period. 200 mg/kg/day, the steady state in salicylate serum levels were achieved on the 4th day from the beginning of the test. The serum levels were estimated daily at 8 o’clock a.m. and, on the first, fifth and tenth day, the blood samples were drawn more frequently, at two hours intervals until 8 hours after the intake of the medicine for to clarify the maximum serum level reached during the test. During the steady state, in the morning samples, salicylate serum concentrations varied between 10 and 20 mg/100 ml, which corres- pond to 900 to 1400 umol/1. The variations of the salicylate serum levels on the first and lOth day are seen in detail in Figure 2. During the steady state, the maxi- mum of salicylate serum leVel were reached 8 hours after the intake of the medicine. The half-life of salicylates in serum is known to increase with increasing dosage. Correspon- dingly, the time interval from the beginning of a constant dosage of salicylates until the steady state grows the longer the higher the daily dose is. In our earlier study with salicylates, we have shown, that if the dosage of salicylates is about 100 mg/kg of body weight daily, the time interval from the beginning to the steady state is between 6 and 7 days. The daily dosage of salicylates of 100 mg/kg of body weight was also demonstrated to be too high, leading to salicylate intoxication in about one third of the cases. The same phenomenon was observed with different salicylate preparations. In Figure 3, the test was done with Bayer's Aspirin, and, in Figure 4 are shown the similar results with the enteric coated form of acetylsalicylic acid. In the present study with benorylate, the serum salicylate levels were lower than expected. In the morning samples during the steady state the serum salicylate levels were only between 10 and 20 mg/100 ml, which corresponds to 900 to 1400 umol/1. The serum levels did not reach the values induced by sole salicylate administration of 100 mg/kg of body weight daily. The lower serurn levels may be due to incomplete absorption (jmol/l mg/IOOml Fig. 3. Salicylate serum levels in children treated with Asprin "Bayer" the daily dosage being about 100 mg/kg of body weight. Days of treatment 45
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.